Patients should talk to a physician if GLP-1 medication causes symptoms that interfere with daily life
TRANSCEND-T2D-1 Results by Dose (40 Weeks) The 16.8% weight loss in this population is substantially below TRIUMPH-1's 28.3% a pattern consistent across the GLP-1 drug class, where type 2 diabetes reduces the magnitude of weight loss compared to non-diabetic obesity populations
"Manufacturing Excellence in Peptide API Production: Quality Systems and Process Optimization." Industrial Pharmacy International, 2023
Semaglutide and tirzepatide are different molecules with different potencies
Skeptical but curious, I gave them a shotand Im so glad I did
Semaglutide works by: Stimulates insulin production in the pancreas Reduces sugar production in the liver Slows down digestion, so food stays in the stomach longer Decreases appetite and food intake These combined actions help you feel full longer, eat less, and maintain better control over blood sugar levels